Apollo Medical Stock Fair Value – Apollo Medical Holdings’ Shareholder Returns Outperform Earnings Growth Over Three Years

☀️Trending News

Apollo Medical ($NASDAQ:AMEH) Holdings, Inc. (Apollo) is a leading healthcare provider and physician network that is dedicated to providing high-quality medical services across the United States. The company has been successful in delivering superior results for shareholders over a three-year period with total returns outperforming underlying earnings growth.

However, looking at the last year, the stock has performed relatively poorly in comparison to past years. This is largely due to several macroeconomic factors that have affected the sector. Furthermore, the increasing competition in the sector is putting pressure on Apollo’s market share and profitability. Despite these challenges, management remains positive and continues to focus on strategies to increase efficiency and profitability. Overall, Apollo Medical Holdings continues to be a potential long-term investment, as the company has shown a track record of delivering outstanding returns for shareholders over the three-year period. Investors should continue to monitor the company and look for further indications of future performance in the coming quarters.

Earnings

APOLLO MEDICAL Holdings, Inc. posted its earnings report for the first quarter of fiscal year 2023 as of March 31, 2021. Total revenue was recorded at 174.39M USD, while net income totaled 13.15M USD. This represents a 33.4% decrease in total revenue and a 7.8% decrease in net income, compared to the same period in the previous year.

Despite the decreases, APOLLO MEDICAL has seen significant growth over the last three years: total revenues increased from 174.39M USD to 335.62M USD during that time. As a result, APOLLO MEDICAL’s shareholder returns have outperformed its earnings growth over the last three years.

About the Company

Income Snapshot

Below shows the total revenue, net income and net margin for Apollo Medical. More…

Cash Flow Snapshot

Below shows the cash from operations, investing and financing for Apollo Medical. More…

Balance Sheet Snapshot

Below shows the total assets, liabilities and book value per share for Apollo Medical. More…

Key Ratios Snapshot

Some of the financial key ratios for Apollo Medical are shown below. More…

Share Price

On Thursday, APOLLO MEDICAL’s stock opened at $30.2 and closed at $29.8, representing a decrease of 2.4% from its previous closing price of $30.6. This demonstrates that investors have continued to find value in APOLLO MEDICAL’s stock, even though its earnings growth has been relatively muted. Live Quote…

Analysis – Apollo Medical Stock Fair Value

At GoodWhale, we recently conducted a financial analysis of APOLLO MEDICAL. After crunching the numbers, we have determined that the intrinsic value of one APOLLO MEDICAL share is around $53.9. This value was determined by our proprietary Valuation Line, which takes into account a variety of factors such as the company’s profitability, growth rate, and other metrics. At the time of our analysis, APOLLO MEDICAL stock was traded at $29.8 – meaning it is currently undervalued by 44.7%. We believe this presents a great opportunity for investors looking to get in on a promising stock at a bargain. More…

Peers

The healthcare industry is highly competitive, with Apollo Medical Holdings Inc competing against some of the largest companies in the world.

However, Apollo has been able to maintain a strong position in the industry through its innovative products and services. The company has a strong focus on research and development, which has allowed it to bring new and innovative products to market. Additionally, Apollo has a strong marketing and sales force that has helped it to gain market share.

– HealthCare Global Enterprises Ltd ($BSE:539787)

HealthCare Global Enterprises Ltd has a market cap of 41.71B as of 2022, a Return on Equity of 13.62%. The company is a leading provider of healthcare services in India with a network of over 30 hospitals across the country. The company offers a comprehensive range of services including medical and surgical care, diagnostics, and preventive healthcare.

– Cano Health Inc ($NYSE:CANO)

Cano Health Inc is a healthcare services company that operates primary care and specialty care clinics in the United States. The company has a market cap of 828.58M as of 2022 and a Return on Equity of -2.88%. Cano Health Inc provides healthcare services to patients through its network of primary care and specialty care clinics. The company offers a range of services including primary care, specialty care, and behavioral health services. Cano Health Inc also provides pharmacy services and operates a laboratory.

– Dhanvantri Jeevan Rekha Ltd ($BSE:531043)

Dhanvantri Jeevan Rekha Ltd is a publicly traded company with a market cap of 64.14M as of 2022. The company’s Return on Equity is 3.31%. Dhanvantri Jeevan Rekha Ltd is engaged in the business of providing healthcare services in India. The company offers a wide range of services including medical consultation, diagnostics, surgery, and other treatments.

Summary

Apollo Medical Holdings (APOLLO) has achieved impressive total shareholder returns over the past three years, surpassing their underlying earnings growth. Investors have been generally pleased with the company’s performance, though the stock has not seen an equivalent surge in value. APOLLO’s business model, which focuses on providing integrated healthcare services, has been seen to be highly lucrative, bringing in huge profits and allowing for long-term success.

Additionally, the company’s focus on creating innovative and cost-effective solutions has allowed them to remain competitive in a crowded market. With strong financials and an effective long-term strategy, APOLLO is well-positioned to continue rewarded investors for the foreseeable future.